Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
慢性骨髄性白血病を治療するためのＮ−メチル−２−［３−（（Ｅ）−２−ピリジン−２−イル−ビニル）−１Ｈ−インダゾール−６−イルスルファニル］−ベンズアミド
Year of Publication 11.12.2014
Get full text
Patent
造血器疾患併発感染症に対するcefpiromeとamik訊cinの併用療法の臨床的検
川井, 信孝, 平嶋, 邦猛, 福田, 正高, 小林, 功幸, 遠藤, 一博, 別所, 正美, 富永, 一則
Published in The Japanese Journal of Antibiotics (1998)
Published in The Japanese Journal of Antibiotics (1998)
Get full text
Journal Article
医学的適用用の３−（１，２，４−トリアゾロ［４，３−ａ］ピリジン−３−イルエチニル）−４−メチル−Ｎ−（４−（（４−メチルピペラジン−１−イル）メチル）−３−トリフルオロメチルフェニル）ベンズアミドの新規な結晶性塩形態
Year of Publication 18.10.2018
Get full text
Patent
Concurrence of imatinib-induced massive pleural/pericardial effusion and Campylobacter bacteremia in an adolescent with chronic myeloid leukemia
Su, Po-Yu, Tan, Boon Fatt, Fu, Chun-Min, Chen, Chi-Nien, Chou, An-Kuo, Kung, Po-Jung, Liao, Ling-Chun, Li, Meng-Ju
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01.01.2022)
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01.01.2022)
Get full text
Journal Article
Systematic review of pre-clinical chronic myeloid leukaemia
Kuan, Jew Win, Su, Anselm Ting, Leong, Chooi Fun, Osato, Motomi, Sashida, Goro
Published in International journal of hematology (01.11.2018)
Published in International journal of hematology (01.11.2018)
Get full text
Journal Article
The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group
Takano, Hina, Sakamoto, Junichi, Sakamaki, Hisashi, Kimura, Shinya, Hino, Masayuki, Hashino, Satoshi, Nakaseko, Chiaki, Uchiyama, Michihiro, Ohashi, Kazuteru, Inokuchi, Koiti, Morita, Satoshi, Iriyama, Noriyoshi
Published in Internal Medicine (01.01.2018)
Published in Internal Medicine (01.01.2018)
Get full text
Journal Article